NASDAQ:KYNB • US31572Q8814
ChartMill assigns a Buy % Consensus number of 80% to KYNB. The Buy consensus is the weighted average rating of the current analysts ratings.
8 analysts have analysed KYNB and the average price target is 43.86 USD. This implies a price increase of 444.84% is expected in the next year compared to the current price of 8.05.
The consensus rating for KYNTRA BIO INC (KYNB) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.